Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| MTX | PRESS-RELEASE | mixed | 6/10 | Minerals Technologies reported Q1 2026 GAAP EPS of $1.17 ($1.38 ex-special items) on net sales of $546.9M, an 11% YoY in | Apr 30, 2026 |
| SLGB | PRESS-RELEASE | bearish | 7/10 | Smart Logistics Global reported FY2025 results with a 7.3% revenue decline to RMB628.5M and a swing to net loss of RMB18 | Apr 30, 2026 |
| KGC | PRESS-RELEASE | bearish | 6/10 | Kinross Gold reported Q1 2026 EPS of $0.71, missing consensus estimates of $0.75 by 5.8%. The miss comes despite a stron | Apr 30, 2026 |
| XOS | PRESS-RELEASE | neutral | 1/10 | Xos, Inc. announced it will report its Q1 2026 results on May 14, 2026. | Apr 30, 2026 |
| DBVT | PRESS-RELEASE | bullish | 5/10 | DBV Technologies reported Q1 2026 EPS of $(0.11), beating consensus of $(0.12) by 8.3%, and revenue of $0.9M, beating $8 | Apr 30, 2026 |
| UMH | PRESS-RELEASE | neutral | 4/10 | UMH Properties reported Q1 2026 Normalized FFO of $0.23 per share, in line with the $0.23 consensus estimate. Total inco | Apr 30, 2026 |
| HFBL | PRESS-RELEASE | bullish | 6/10 | Home Federal Bancorp reported Q3 2025 net income of $1.472M ($0.49 basic EPS), nearly double the $748K ($0.24) a year ag | Apr 30, 2026 |
| EBS | PRESS-RELEASE | mixed | 6/10 | Emergent BioSolutions reported Q1 2026 adjusted net income per diluted share of $0.21, beating the consensus estimate of | Apr 30, 2026 |
| CUBE | PRESS-RELEASE | neutral | 4/10 | CubeSmart reported Q1 2026 FFO as adjusted of $0.63 per share, in line with the $0.62 consensus (a 1.6% beat). Same-stor | Apr 30, 2026 |
| CUE | PRESS-RELEASE | mixed | 6/10 | Cue Biopharma licensed global rights (ex-China) to Ascendant-221, a Phase 2 anti-IgE antibody for allergic diseases, fro | Apr 30, 2026 |
| SYK | PRESS-RELEASE | bearish | 8/10 | Stryker reported Q1 2026 GAAP EPS of $1.93 (vs consensus $2.98, a 35.2% miss) and adjusted EPS of $2.60 (down 8.5% YoY). | Apr 30, 2026 |
| EXPO | PRESS-RELEASE | mixed | 5/10 | Exponent reported Q1 2026 GAAP EPS of $0.59, missing the $0.61 consensus by 3.3%, while revenue of $166.3M beat the $153 | Apr 30, 2026 |
| JAKK | PRESS-RELEASE | bearish | 6/10 | JAKKS Pacific reported Q1 2026 net sales of $106.7M (-6% YoY) and a GAAP net loss of $0.37/share, wider than the $0.21 l | Apr 30, 2026 |
| AKBA | PRESS-RELEASE | neutral | 1/10 | Akebia Therapeutics, Inc. announced it will report its Q1 2026 results on May 7. | Apr 30, 2026 |
| LESL | PRESS-RELEASE | neutral | 1/10 | Leslie’s Inc. announced it will report its Q2 2026 results on May 13, 2026. | Apr 30, 2026 |
| CV | PRESS-RELEASE | neutral | 1/10 | CapsoVision announced it will report its Q1 2026 results on May 14, 2026. | Apr 30, 2026 |
| BOOM | PRESS-RELEASE | bearish | 7/10 | DMC Global reported Q1 2026 GAAP EPS of -$0.34 (vs consensus -$0.33, a miss) and revenue of $135.6M (vs consensus $134.1 | Apr 30, 2026 |
| MMSI | PRESS-RELEASE | bullish | 7/10 | Merit Medical reported Q1 2026 EPS of $0.94 (non-GAAP, the Street convention), beating the $0.83 consensus by 13.3%, and | Apr 30, 2026 |
| IRTC | PRESS-RELEASE | bullish | 8/10 | iRhythm reported Q1 2026 revenue of $199.4M (+25.7% YoY) and GAAP EPS of -$0.43, beating consensus estimates of $194.1M | Apr 30, 2026 |
| IPSC | PRESS-RELEASE | neutral | 3/10 | Century Therapeutics announced an oral presentation at the ADA 86th Scientific Sessions (June 5-8, 2026) highlighting pr | Apr 30, 2026 |
| JCAP | PRESS-RELEASE | neutral | 2/10 | Jefferson Capital announced it will release Q1 2026 financial results after market close on May 14, 2026, followed by a | Apr 30, 2026 |
| NEPH | PRESS-RELEASE | neutral | 1/10 | Nephros, Inc. announced it will host a conference call to discuss its Q1 2026 results. | Apr 30, 2026 |
| VIVK | PRESS-RELEASE | neutral | 2/10 | Vivakor resets the payment date of its previously announced special dividend to June 30, 2026, due to pending SEC filing | Apr 30, 2026 |
| AXSM | PRESS-RELEASE | bullish | 8/10 | Axsome Therapeutics announced FDA approval of AUVELITY (dextromethorphan HBr/bupropion HCl) for agitation associated wit | Apr 30, 2026 |
| KAI | PRESS-RELEASE | neutral | 1/10 | Kadant Inc announced it will host a conference call on May 6, 2026 to discuss its Q1 2026 results. | Apr 30, 2026 |
| UFPT | PRESS-RELEASE | neutral | 1/10 | UFP Technologies, Inc. announced it will report its Q1 2026 results on May 4, 2026. | Apr 30, 2026 |
| WULF | PRESS-RELEASE | neutral | 1/10 | TeraWulf Inc. announced it will host a conference call on May 8, 2026 to discuss its Q1 2026 results. | Apr 30, 2026 |
| SAM | PRESS-RELEASE | neutral | 2/10 | Dogfish Head (SAM) announced a limited-edition collaborative beer, Coconut Etiquette, with CBS's Survivor to celebrate t | Apr 30, 2026 |
| MNST | PRESS-RELEASE | neutral | 1/10 | Monster Beverage Corporation announced it will report its Q1 2026 results on May 7, 2026. | Apr 30, 2026 |
| TIGO | PRESS-RELEASE | neutral | 1/10 | Millicom International Cellular S.A. announced it will host a conference call on May 12, 2026 to discuss its Q1 2026 res | Apr 30, 2026 |